Will Adjuvant Oxaliplatin Data Change Practice in CRC? Will Adjuvant Oxaliplatin Data Change Practice in CRC?

Dr John Marshall previews the GI cancer studies being presented at ASCO with his picks for the ones to watch, and predicts that a plenary presentation may be practice-changing.Medscape Oncology
Source: Medscape Today Headlines - Category: Consumer Health News Tags: Hematology-Oncology Commentary Source Type: news